The W8E7 monoclonal antibody (Anti-CALLA) specifically recognizes CD10. The W8E7 antibody recognizes a 100 kDa human common acute lymphoblastic leukemia antigen (CALLA). The CD10 antigen is identical to human membrane-associated neutral endopeptidase (NEP), also known as enkephalinase. The CD10 antigen is found on lymphocytes from acute B-lymphoid leukemia samples. The antigen is also present on a wide variety of normal and neoplastic cell types including early B-lineage cells, germinal center B cells, fetal thymocytes, granulocytes, renal epithelium, fibroblasts, and some lymphoma, melanoma, and glioma cell lines.
The antibody was conjugated to BD Horizon™ BUV661 which is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This dye is a tandem fluorochrome of BD Horizon BUV395 with an Ex Max of 348-nm and an acceptor dye with an Em Max at 661-nm. BD Horizon Brilliant BUV661 can be excited by the ultraviolet laser (355 nm) and detected with a 670/25 filter and a 630 nm LP. Due to cross laser excitation of this dye, there may be significant spillover into channels detecting APC-like emissions (eg, 670/25-nm filter).
Due to spectral differences between labeled cells and beads, using BD™ CompBeads can result in incorrect spillover values when used with BD Horizon BUV661 reagents. Therefore, the use of BD CompBeads or BD CompBeads Plus to determine spillover values for these reagents is not recommended. Different BUV661 reagents (eg, CD4 vs. CD45) can have slightly different fluorescence spillover therefore, it may also be necessary to use clone-specific compensation controls when using these reagents.